Conditions: Insomnia Asthma
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 2
Healthy volunteers: no

Brief summary:
This trial will test the efficacy and safety of ramelteon, a selective melatonin agonist, on patients with insomnia comorbid with asthma.

Detailed description:
Subjects with insomnia comorbid with asthma will be randomized to placebo or ramelteon at night for 6 weeks.

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Ramelteon
Intervention descriptions: intervention 1: melatonin agonist

Protocol document: